Published in Thromb Res on May 15, 1990
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell (1999) 8.55
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04
Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia (2001) 4.22
A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol (1985) 3.02
Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc Natl Acad Sci U S A (2000) 2.54
Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers. Clin Pharmacol Ther (1981) 2.36
Detection and sequence of mutations in the factor VIII gene of haemophiliacs. Nature (1985) 2.30
TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem (1996) 2.13
A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects. Br J Clin Pharmacol (1982) 2.06
Prothrombin is activated on vascular endothelial cells by factor Xa and calcium. Proc Natl Acad Sci U S A (1983) 2.06
Redistribution of alpha-granules and their contents in thrombin-stimulated platelets. J Cell Biol (1984) 2.06
Genetic distribution of Bare-1-like retrotransposable elements in the barley genome revealed by sequence-specific amplification polymorphisms (S-SAP). Mol Gen Genet (1997) 2.05
Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature (2000) 2.04
Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci U S A (1999) 2.01
Analysis and purification of human lymphoblastoid (Namalwa) interferon using a monoclonal antibody. J Gen Virol (1982) 2.01
Export of proteins from oocytes of Xenopus laevis. Cell (1979) 2.01
Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem (1999) 1.96
Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci U S A (1993) 1.82
Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521. Br J Clin Pharmacol (1982) 1.81
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study. Cancer Res (2001) 1.71
Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS (1994) 1.68
Characterization of the effects of cultured vascular cells on the activation of blood coagulation. Blood (1983) 1.63
Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves. Blood (1988) 1.60
Identification of a missense mutation in the factor VIII gene of a mild hemophiliac. Science (1986) 1.60
An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells. Nature (1987) 1.57
The measurement of thrombin in clotting blood by radioimmunoassay. J Clin Invest (1976) 1.56
Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am J Pathol (2001) 1.48
The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering. J Cell Biol (1987) 1.47
Thrombin-cellular interactions. Ann N Y Acad Sci (1986) 1.47
Direct effects of protein S in ameliorating acute lung injury. J Thromb Haemost (2009) 1.46
Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res (1996) 1.45
Anaphylactoid reactions to vascular graft material presenting with vasodilation and subsequent disseminated intravascular coagulation. Anesthesiology (1989) 1.39
Biogenesis of the platelet receptor for fibrinogen: evidence for separate precursors for glycoproteins IIb and IIIa. Proc Natl Acad Sci U S A (1986) 1.37
Retracted Target platelet antigen in homosexual men with immune thrombocytopenia. N Engl J Med (1985) 1.36
The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res (1994) 1.36
Initiation of translation directed by 42S and 26S RNAs from Semliki Forest virus in vitro. Proc Natl Acad Sci U S A (1976) 1.35
Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res (1996) 1.35
Platelet glycoprotein IIb. Chromosomal localization and tissue expression. J Clin Invest (1987) 1.31
Cloning of glycoprotein IIIa cDNA from human erythroleukemia cells and localization of the gene to chromosome 17. Blood (1988) 1.27
Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. J Clin Invest (1992) 1.27
Endocytosis of fibrinogen into megakaryocyte and platelet alpha-granules is mediated by alpha IIb beta 3 (glycoprotein IIb-IIIa) Blood (1993) 1.25
The influence of topology and glycosylation on the fate of heterologous secretory proteins made in Xenopus oocytes. Eur J Biochem (1981) 1.25
Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int J Cancer (1995) 1.23
Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. J Clin Invest (1998) 1.21
Immunohistochemical localization of membrane and alpha-granule proteins in human megakaryocytes: application to plastic-embedded bone marrow biopsy specimens. Blood (1986) 1.19
Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells. Blood (1991) 1.17
Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats. Mol Pharmacol (1997) 1.16
The normal range for inter-arm differences in blood pressure. Age Ageing (1999) 1.14
Incorporation of a circulating protein into megakaryocyte and platelet granules. Proc Natl Acad Sci U S A (1987) 1.14
Atenolol disposition in young and elderly subjects. Br J Clin Pharmacol (1982) 1.13
Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost (1997) 1.13
The Xenopus oocyte as a surrogate secretory system. The specificity of protein export. Eur J Biochem (1980) 1.11
Characteristics of the membrane defect in the hereditary stomatocytosis syndrome. Blood (1975) 1.11
Effect of age on the responsiveness of vascular alpha-adrenoceptors in man. J Cardiovasc Pharmacol (1982) 1.10
The zymogen forms of blood coagulation factor XIII bind specifically to fibrinogen. J Biol Chem (1982) 1.10
Physical linkage of the genes for platelet membrane glycoproteins IIb and IIIa. Proc Natl Acad Sci U S A (1988) 1.08
The binding of human and bovine thrombin to human platelets. Blood (1976) 1.08
The perturbation of thrombin binding to human platelets by anions. J Clin Invest (1975) 1.07
Optimal techniques for the immunocytochemical demonstration of beta-thromboglobulin, platelet factor 4, and fibrinogen in the alpha granules of unstimulated platelets. Histochem J (1984) 1.06
Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules. J Clin Invest (1989) 1.06
Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation. J Biol Chem (2000) 1.04
Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med (1997) 1.03
KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun (2000) 1.03
Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic. AIDS (2000) 1.03
Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting. J Clin Invest (1980) 1.02
Calcium antagonists decrease adrenal and vascular responsiveness to angiotensin II in normal man. Clin Sci (Lond) (1981) 1.01
Expression efficiency of the human thrombomodulin-encoding gene in various vector and host systems. Gene (1994) 0.99
Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains. J Biol Chem (1999) 0.98
Identification of an abnormal gene for the GPIIIa subunit of the platelet fibrinogen receptor resulting in Glanzmann's thrombasthenia. Blood (1990) 0.98
Simultaneous translation of structural and nonstructural proteins from Semliki-forest-virus RNA in two eukaryotic systems in vitro. Eur J Biochem (1976) 0.98
Evaluation of a direct immunofluorescence test for diagnosing gonorrhoea. J Clin Pathol (1985) 0.96
Modulation of glycosaminoglycan addition in naturally expressed and recombinant human thrombomodulin. J Biol Chem (1994) 0.96
Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor. J Biol Chem (1998) 0.95
Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity. J Biol Chem (1993) 0.95
The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function. J Biol Chem (1993) 0.95
The number of receptors for factor VII correlates with the ability of cultured cells to initiate coagulation. Blood (1984) 0.94
Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation. Blood (1986) 0.94
Thrombin generation and secretion of platelet Factor 4 during blood clotting. J Clin Invest (1978) 0.94
Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group. AIDS Res Hum Retroviruses (1998) 0.94
Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer. Int J Cancer (1995) 0.94
Topographic distribution of a granule membrane protein (GMP-140) that is expressed on the platelet surface after activation: an immunogold-surface replica study. Blood Cells (1986) 0.93
Internalization and degradation of thrombin and up regulation of thrombin-binding sites in corneal endothelial cells. J Biol Chem (1981) 0.92
Clinical evaluation of endralazine (BO22708), a new vasodilator, in essential hypertension. Clin Exp Hypertens A (1982) 0.92
Recurrence after laparoscopic and open Nissen fundoplication: a comparison of the mechanisms of failure. Surg Endosc (2003) 0.91
Fate of secretory proteins trapped in oocytes of Xenopus laevis by disruption of the cytoskeleton or by imbalanced subunit synthesis. J Cell Biol (1981) 0.91
Expression of interferon-alpha and interferon-beta genes in human lymphoblastoid (Namalwa) cells. Eur J Biochem (1983) 0.91
An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model. Thromb Res (2000) 0.90
Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets. J Biol Chem (1984) 0.90
FXa-induced responses in vascular wall cells are PAR-mediated and inhibited by ZK-807834. Thromb Res (2001) 0.89
The isolation of vascular endothelial cell lines with altered cell surface and platelet-binding properties. Cell (1978) 0.89
Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules. J Clin Invest (1993) 0.89
Human platelets and megakaryocytes contain alternately spliced glycoprotein IIb mRNAs. J Biol Chem (1990) 0.89
Characterization of interferon messenger RNA from human lymphoblastoid cells. J Gen Virol (1979) 0.88
Acquired Bernard-Soulier syndrome. Evidence for the role of a 210,000-molecular weight protein in the interaction of platelets with von Willebrand factor. J Clin Invest (1985) 0.87
A link between prompt optical and prompt gamma-ray emission in gamma-ray bursts. Nature (2005) 0.87
The Ty1-copia group of retrotransposons in plants: genomic organisation, evolution, and use as molecular markers. Genetica (1997) 0.87